Coronavirus Vaccine in the U.S.

Coronavirus Vaccine in the U.S. Superforecasters see a 53% probability that 25 million doses of an FDA-approved COVID-19 vaccine will be available by March 2021 vs. 69% two weeks ago. Image: Goldman Sachs Global Investment Research

Coronavirus Vaccine and Jet Fuel Demand

Coronavirus Vaccine and Jet Fuel Demand Goldman Sachs expects jet fuel demand to recover next year, with the availability of a coronavirus vaccine by the second-quarter of 2021. Image: Goldman Sachs Global Investment Research

Coronavirus Vaccine in the U.S.

Coronavirus Vaccine in the U.S. A vaccine for Covid-19 will accelerate the path to economic normalization. Image: Goldman Sachs Global Investment Research

Coronavirus Vaccine in the United States

Coronavirus Vaccine in the United States Will a coronavirus vaccine be approved by the FDA between October 2020 and March 2021? Image: Goldman Sachs Global Investment Research

Coronavirus Crisis and U.S. Corporate Bankruptcies

Coronavirus Crisis and U.S. Corporate Bankruptcies The coronavirus crisis triggers a record number of U.S. corporate bankruptcies, despite record levels of federal aid. Image: Financial Times

U.S. Real GDP Relative to Pre-Coronavirus Level

U.S. Real GDP Relative to Pre-Coronavirus Level Goldman Sachs is optimistic and has raised its 2021 estimate of U.S. real GDP growth to 6.2%. Image: Goldman Sachs Global Investment Research